Wird geladen...
Contemporary use of P2Y(12) inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry
According to guidelines, it is recommended to give P2Y(12) inhibitors (preferably ticagrelor or prasugrel) at the time of first medical contact in patients with STEMI. However, in real life antiplatelet treatment strategies are different among countries. We analyzed data on antiplatelet treatment in...
Gespeichert in:
| Veröffentlicht in: | J Thromb Thrombolysis |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756271/ https://ncbi.nlm.nih.gov/pubmed/29075924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-017-1579-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|